Merck cut a drug discovery cycle by 33% and ships compliant marketing 80% faster. Mastercard is rethinking fraud disputes.
Artificial intelligence is poised to take on a more-active role in the laboratory: two new systems, described today in Nature ...
Scalable, parallel drug design: one researcher can run multiple campaigns simultaneously across targets and modalities From research goal to lab-ready sequences in hours: Latent-Y compresses weeks of ...
Tech Xplore on MSN
AI assistants can accelerate scientific discoveries by helping design and interpret experiments
Two artificial intelligence (AI) systems that can assist throughout multiple processes involved in scientific research—such ...
Databricks has outlined a reference architecture for a multi-agent AI system, named AiChemy, that combines internal enterprise data on its platform with external scientific databases via the Model ...
Zacks Investment Research on MSN
QIAGEN stock up on the launch of AI-powered workflow agent platform
QIAGEN QGEN recently launched QIA Agent, an AI-powered digital assistant designed to simplify how researchers plan ...
Discover how agentic AI can improve compound and sample management for laboratories, prepare documentation, and improve data ...
The assembly line upended manufacturing last century—could teams of agents do the same for white-collar work? When people say AI will speed up drug development or fear that it will bring about mass ...
Today, Latent Labs launches Latent-Y, an AI agent that autonomously designs therapeutic antibodies from a text prompt, compressing weeks of expert work into hours. Powered by Latent-X2, Latent Labs' ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results